Comments
Dr Reddy’s Laboratories on Friday said it has launched the Deferasirox tablets for oral suspension used for treatment of chronic iron overload, in the US market. The company has launched its product, a generic version of Novartis Pharma AG’s Exjade tablets for oral suspension, after getting the nod from the United States Food and Drug Administration (USFDA), Dr Reddy’s Labs said in a filing to the BSE. According to IQVIA Health data, the Exjade brand had US sales of around $113 million MAT for 12 months to September 2019, it added. Shares of Dr Reddy’s gained 0.76 per cent at ₹2,891.95 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.